Healthcare Services

Gastrointestinal Stromal Tumor Market Outlook Through 2030 With Analysis Of Industry Trends And Developments

May 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Expected Market Value Outlook For The Gastrointestinal Stromal Tumor Market Through 2030?

The gastrointestinal stromal tumor market has demonstrated strong expansion in recent years. This market is forecast to increase from $1.36 billion in 2025 to $1.46 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.9%. Factors contributing to its historical growth include the approval of imatinib therapy, enhanced tumor classification, the proliferation of oncology care centers, greater recognition of rare GI tumors, and the accessibility of surgical interventions.

The gastrointestinal stromal tumor market is projected to witness significant growth in the upcoming years, with its valuation expected to reach $1.98 billion by 2030, driven by a compound annual growth rate (CAGR) of 8.0%. This anticipated growth during the forecast period is primarily attributed to advancements in next-generation targeted therapies, the expansion of precision diagnostics, an increase in clinical trials, the broadening of personalized cancer treatment options, and enhanced survival outcomes. Notable trends over the forecast period include the escalating use of targeted tyrosine kinase inhibitors, a heightened focus on molecular tumor profiling, the expansion of precision oncology approaches, an increase in surgical and drug combination therapies, and improved long-term disease management.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13248&type=smp

What Major Growth Factors Are Impacting The Gastrointestinal Stromal Tumor Market?

The rising occurrence of stomach cancer is projected to fuel the expansion of the gastrointestinal stromal tumor market in the future. Stomach cancer is characterized by the uncontrolled division and proliferation of cancerous cells within the stomach’s inner lining. While gastrointestinal stromal tumors (GISTs) may emerge in the stomach, they are distinct from stomach cancer. It has been observed that individuals with GISTs face an elevated likelihood of developing further cancers, such as small bowel adenocarcinoma, especially when distinct tumors coalesce. As an illustration, in January 2024, the American Cancer Society, a US-based professional organization, predicted approximately 26,890 new stomach cancer cases and 10,880 fatalities in the U.S. for 2024, representing 1.5% of all new cancer diagnoses. Consequently, the increasing prevalence of stomach cancer is propelling the growth of the gastrointestinal stromal tumor market.

What Key Segment Areas Are Included In The Gastrointestinal Stromal Tumor Market Assessment?

The gastrointestinal stromal tumor market covered in this report is segmented –

1) By Treatment Type: Chemotherapy, Targeted Therapy, Other Treatment Types

2) By Indication: Stomach, Small Intestine, Others Indications

3) By End-User: Hospitals, Clinics, Specialized Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Chemotherapy: Traditional Chemotherapy Agents, Combination Chemotherapy Regimens

2) By Targeted Therapy: Tyrosine Kinase Inhibitors, Other Targeted Agents

3) By Other Treatment Types: Surgery, Radiation Therapy, Clinical Trials For Novel Therapies

Which Trends Are Guiding The Development Of The Gastrointestinal Stromal Tumor Market?

Leading companies in the gastrointestinal stromal tumor market are developing innovative drugs, such as signal transduction and targeted therapy, aimed at enhancing treatment effectiveness, overcoming resistance to existing treatments, and addressing unmet clinical demands. Signal transduction and targeted therapy are defined as treatments designed to inhibit or alter specific cellular signaling pathways responsible for tumor growth and survival. For instance, in November 2025, Ascentage Pharma Group International Inc., a China-based commercial-stage biopharmaceutical company, revealed the publication of Phase Ib clinical data for olverembatinib (HQP1351) in Signal Transduction and Targeted Therapy, which showcased encouraging efficacy and safety in SDH-deficient gastrointestinal stromal tumors (GIST) and identified a novel antitumor mechanism involving lipid metabolism modulation.

Who Are The Prominent Players Across The Gastrointestinal Stromal Tumor Market?

Major companies operating in the gastrointestinal stromal tumor market are Pfizer Inc., F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, Merck & Co. Inc., GlaxoSmithKline plc, Bristol-Myers Squibb Company, Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Jiangsu Hengrui Medicine Co. Ltd., Exelixis Inc., NATCO Pharma Ltd., Blueprint Medicines Corporation, Array BioPharma Inc., Deciphera Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd.

Access The Complete Gastrointestinal Stromal Tumor Market Report:

https://www.thebusinessresearchcompany.com/report/gastrointestinal-stromal-tumor-global-market-report

Which Region Is The Dominant Market In The Gastrointestinal Stromal Tumor Market?

North America was the largest region in the gastrointestinal stromal tumor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal stromal tumor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Gastrointestinal Stromal Tumor Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=13248&type=smp

Browse Through More Reports Similar to the Global Gastrointestinal Stromal Tumor Market 2026, By The Business Research Company

Food Pathogen Testing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/food-pathogen-testing-global-market-report

Infectious Disease Diagnostics Testing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

Food Pathogen Safety Testing Equipment And Supplies Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/food-pathogen-safety-testing-equipment-and-supplies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795